Inhaled corticosteroid use for asthma is linked to adrenal suppression

被引：1

作者：

Lasky-Su, Jessica ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

来源：

NATURE MEDICINE | 2022年 / 28卷 / 04期

关键词：

D O I：

10.1038/s41591-022-01732-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The largest metabolomic study of asthma thus far, comprising >14,000 people from four independent cohorts, has found that inhaled corticosteroid (ICS) treatment is associated with adrenal suppression, even at low doses. Thus, ICS dosage should be optimized to minimize adrenal suppression while maintaining its established benefits in asthma management.

引用

页码：645 / 646

页数：2

共 50 条

[1] Inhaled corticosteroid use for asthma is linked to adrenal suppression
Nature Medicine, 2022, 28 : 645 - 646
[2] Omalizumab and allergen immunotherapy in a patient with asthma and inhaled corticosteroid-induced adrenal suppression
Forbush, Jason T.
Banks, Taylor A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (03) : 335 - 337
[3] Adrenal suppression, asthma and inhaled steroids
Isaacs, David
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2017, 53 (10) : 1027 - 1028
[4] Inhaled Corticosteroid-Induced Adrenal Suppression in Patients With Asthma Detected by Metabolomic Profiling
Chiarella, Sergio E.
Bancos, Irina
Ortega, Victor E.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10) : 2774 - 2775
[5] Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma
Priyadarshini Kachroo
Isobel D. Stewart
Rachel S. Kelly
Meryl Stav
Kevin Mendez
Amber Dahlin
Djøra I. Soeteman
Su H. Chu
Mengna Huang
Margaret Cote
Hanna M. Knihtilä
Kathleen Lee-Sarwar
Michael McGeachie
Alberta Wang
Ann Chen Wu
Yamini Virkud
Pei Zhang
Nicholas J. Wareham
Elizabeth W. Karlson
Craig E. Wheelock
Clary Clish
Scott T. Weiss
Claudia Langenberg
Jessica A. Lasky-Su
Nature Medicine, 2022, 28 : 814 - 822
[6] Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma
Kachroo, Priyadarshini
Stewart, Isobel D.
Kelly, Rachel S.
Stav, Meryl
Mendez, Kevin
Dahlin, Amber
Soeteman, Djora I.
Chu, Su H.
Huang, Mengna
Cote, Margaret
Knilhtila, Hanna M.
Lee-Sarwar, Kathleen
McGeachie, Michael
Wang, Alberta
Wu, Ann Chen
Virkud, Yamini
Zhang, Pei
Wareham, Nicholas J.
Karlson, Elizabeth W.
Wheelock, Craig E.
Clish, Clary
Weiss, Scott T.
Langenberg, Claudia
Lasky-Su, Jessica A.
NATURE MEDICINE, 2022, 28 (04) : 814 - 822
[7] Prevalence of Hypothalamic-Pituitary-Adrenal Axis Suppression in Children Treated for Asthma with Inhaled Corticosteroid
Smith, R. W.
Downey, K. K.
Gordon, M.
Hudak, A.
Meeder, R.
Barker, S.
Chroinin, M. Ni
Smith, W. G.
IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S451 - S451
[8] Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid
Smith, Ryan W.
Downey, Kim
Gordon, Michelle
Hudak, Alan
Meeder, Rob
Barker, Sarah
Smith, W. Gary
PAEDIATRICS & CHILD HEALTH, 2012, 17 (05) : E34 - E39
[9] Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
Anuradha KWDA
Prematilake GLDC
Batuwita BAUI
Kannangoda KASR
Hewagamage US
Wijeratne S
Lankatilake Kantha
de Silva KSH
BMC Pediatrics, 19
[10] Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
Anuradha, K. W. D. A.
Prematilake, G. L. D. C.
Batuwita, B. A. U., I
Kannangoda, K. A. S. R.
Hewagamage, U. S.
Wijeratne, S.
Kantha, Lankatilake
de Silva, K. S. H.
BMC PEDIATRICS, 2019, 19 (01)

← 1 2 3 4 5 →